Dr Agarwals Health Care Ltd

Dr Agarwal's Hea Summary Chart Analysis Peers Quarters Profit & Loss Balance Sheet Cash Flow Ratios Investors Documents

Dr Agarwals Health Care Ltd

₹ 413 -1.41%
21 Feb - close price
dragarwals.co.in BSE: 544350 NSE: AGARWALEYE
About

Incorporated in 2010, Dr. Agarwal's Health Care Limited provides a wide spectrum of eye care services and the retailing of optical products, contact lenses, accessories, and eye care-related pharmaceuticals.[1]

Key Points

Largest Eyecare Service Provider[1]
Dr. Agarwal is India's largest eye care service chain with a 25% market share. It is the largest company by revenue in FY23, with more than two times the revenue from operations of the second-largest eye care service chain in the country.

Website BSE NSE
  • Market Cap ₹ 13,033 Cr.
  • Current Price ₹ 413
  • High / Low ₹ 464 / 366
  • Stock P/E 191
  • Book Value ₹
  • Dividend Yield 0.00 %
  • ROCE 11.2 %
  • ROE 6.94 %
  • Face Value ₹ 1.00
Edit ratios

Pros

Cons

  • Promoter holding has decreased over last quarter: -5.38%
  • Company has a low return on equity of 12.3% over last 3 years.

* The pros and cons are machine generated. Pros / cons are based on a checklist to highlight important points. Please exercise caution and do your own analysis.

Peer comparison

Sector: Healthcare Industry: Healthcare

Part of BSE IPO

Edit Columns
Loading peers table ...

Quarterly Results

Consolidated Figures in Rs. Crores / View Standalone

Dec 2023 Sep 2024 Dec 2024
333 417 431
244 310 316
Operating Profit 89 107 115
OPM % 27% 26% 27%
12 12 13
Interest 22 28 28
Depreciation 43 57 58
Profit before tax 36 33 41
Tax % 37% 36% 31%
23 21 28
EPS in Rs 0.72
Raw PDF

Profit & Loss

Consolidated Figures in Rs. Crores / View Standalone

Mar 2020 Mar 2021 Mar 2022 Mar 2023 Mar 2024
531 471 696 1,018 1,332
407 387 510 743 965
Operating Profit 124 85 186 275 367
OPM % 23% 18% 27% 27% 28%
13 6 17 14 44
Interest 54 44 49 76 101
Depreciation 93 95 98 128 170
Profit before tax -11 -48 57 84 141
Tax % 82% 21% 24% -24% 32%
-21 -59 43 103 95
EPS in Rs
Dividend Payout % 0% 0% 0% 0% 0%
Compounded Sales Growth
10 Years: %
5 Years: %
3 Years: 41%
TTM: 31%
Compounded Profit Growth
10 Years: %
5 Years: %
3 Years: 48%
TTM: -25%
Stock Price CAGR
10 Years: %
5 Years: %
3 Years: %
1 Year: %
Return on Equity
10 Years: %
5 Years: %
3 Years: 12%
Last Year: 7%

Balance Sheet

Consolidated Figures in Rs. Crores / View Standalone

Mar 2020 Mar 2021 Mar 2022 Mar 2023 Mar 2024 Sep 2024
Equity Capital 7 7 7 8 9 31
Reserves 242 177 206 622 1,330 1,474
162 185 633 857 966 1,034
339 417 179 336 445 855
Total Liabilities 751 787 1,025 1,823 2,751 3,393
551 575 701 1,293 1,746 2,381
CWIP 8 11 28 99 118 122
Investments 1 0 0 34 471 324
192 201 295 397 416 566
Total Assets 751 787 1,025 1,823 2,751 3,393

Cash Flows

Consolidated Figures in Rs. Crores / View Standalone

Mar 2020 Mar 2021 Mar 2022 Mar 2023 Mar 2024
103 99 164 233 346
-85 -46 -155 -509 -914
-73 -37 35 303 553
Net Cash Flow -56 17 44 27 -15

Ratios

Consolidated Figures in Rs. Crores / View Standalone

Mar 2020 Mar 2021 Mar 2022 Mar 2023 Mar 2024
Debtor Days 36 36 30 27 27
Inventory Days 178 169 144 116 138
Days Payable 340 452 389 326 355
Cash Conversion Cycle -126 -247 -215 -183 -190
Working Capital Days -23 -36 -17 -28 -29
ROCE % -1% 17% 13% 11%

Shareholding Pattern

Numbers in percentages

Feb 2025
32.45%
56.97%
5.10%
5.49%
No. of Shareholders 2,17,289

* The classifications might have changed from Sep'2022 onwards. The new XBRL format added more details from Sep'22 onwards.

Classifications such as banks and foreign portfolio investors were not available earlier. The sudden changes in FII or DII can be because of these changes.

Click on the line-items to see the names of individual entities.

Documents

Announcements

Annual reports

No data available.

DRHP

Credit ratings

Concalls